subject: Aarkstore Enterprise---quidel Corporation (qdel) - Financial And Strategic Analysis Review [print this page] Quidel Corporation (Quidel) is a medical device company engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions at the point of care (POC) in infectious diseases and reproductive health. The company focuses on Point of Care testing solutions for physicians office lab and acute care markets globally. It offers products for Bone Health, and for reproductive and womens health, including pregnancy, Chlamydia trachomatis; and infectious diseases, such as Influenza, Group A Strep, and Respiratory Syncitial Virus test. Quidel sells its products in physician offices, hospitals, clinical laboratories, retail clinics and wellness screening centers.
Quidel Corporation Key Recent Developments
Apr 29, 2010: Quidel Reports Total Revenues Of $28.4 Million In Q1 2010
Feb 19, 2010: Quidel Acquires Diagnostic Hybrids
Feb 11, 2010: Quidel Reports Net Income Of $32.9 Million In 2009
Jan 10, 2010: Quidel Signs Agreement To Acquire Diagnostic Hybrids
Oct 16, 2009: Quidel Reports Net Income Of $14.9 Million In Q3 2009
This comprehensive SWOT analysis of Quidel Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
